Dana Investment Advisors, Inc. Blueprint Medicines Corp Transaction History
Dana Investment Advisors, Inc.
- $2.99 Billion
- Q3 2024
A detailed history of Dana Investment Advisors, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 36,792 shares of BPMC stock, worth $3.82 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
36,792
Previous 14,744
149.54%
Holding current value
$3.82 Million
Previous $1.59 Million
114.03%
% of portfolio
0.11%
Previous 0.05%
Shares
18 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$695 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$691 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$560 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$412 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$287 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...